MedTrace Logo

Pain Management Following Sinus Surgery

NCT03822962 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-09-06

No results posted yet for this study

Summary

This Study evaluates the effect of adding Non-steroidal anti-inflammatories (NSAIDs) to the post-operative pain management of sinus surgery patients and wether or not this addition reduces or eliminates the need for narcotic pain medications.

Patients will be instructed to take an NSAID regimen after surgery and will be instructed to take narcotics only for breakthrough pain.

Conditions

  • Nasal Sinus; Inflammation
  • Opioid Abuse
  • Pain, Postoperative

Interventions

DRUG

Ibuprofen 600Mg Tablet

ibuprofen 600 mg by mouth every 8 hours scheduled in addition to standard tylenol regimen.

OTHER

Standard Regimen | Tylenol

Tylenol 1000 mg by mouth every 6 hours scheduled and a rescue prescription of oxycodone 5 mg tablets by mouth every 6 hours as needed for pain. Ten total oxycodone tablets will be prescribed.

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Christie Barnes, MD · University of Nebraska

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-07
Primary Completion
2023-05-30
Completion
2023-05-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03822962 on ClinicalTrials.gov